Search results
Found 10 matches for
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
©
Shutterstock
WHITE-5
Botnar Hip
FAIT
Botnar Hip
FAIT is a multicentre randomised controlled clinical trial comparing surgical and non-surgical approaches to treating femoroacetabular impingement (hip impingement).
Glyn-Jones Group | Hip Research Group
Botnar Hip
Our research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.
MEET FIONA
-
Fiona Powrie FRS
Professor of Musculoskeletal Sciences and Director of the Kennedy Institute
FUNDED BY
Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2
Journal of Experimental Medicine
Find out more about
Similar stories
NDORMS researchers awarded for Dupuytren research
8 April 2021
Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.
Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF
11 March 2021
New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).
A new study maps the expression of innate immune receptors during the course of arthritis
8 March 2021
The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.
International Women's Day
8 March 2021
It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.
Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints
5 March 2021
Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.
NDORMS academics named NIHR Senior Investigators
5 March 2021
Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).